US2941001024 - Common Stock
ENZO BIOCHEM INC
NYSE:ENZ (12/17/2024, 8:55:37 PM)
Premarket: 0.716 +0.02 (+2.29%)0.7
-0.31 (-30.69%)
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company is headquartered in Farmingdale, New York and currently employs 125 full-time employees. The firm's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The firm monetizes its technology primarily via sales through its global distribution network and licensing. The firm conducts its research and other product development efforts through internal research and collaborative relationships.
ENZO BIOCHEM INC
60 Executive Blvd
Farmingdale NEW YORK 10022
P: 15167555500
CEO: Elazar Rabbani
Employees: 185
Website: https://www.enzo.com/
Tuesday's session: top gainers and losers
FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
FARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
Enzo Biochem just reported results for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enzo Biochem (NYSE:ENZ) just reported results for the third quarter of 2024.Enz...
Here you can normally see the latest stock twits on ENZ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: